DurchfallWe have been broken through the low of October/November 2023. In January we did not succeed yet but now we have managed to. Hopefully we can remain under this support until the end of February. But anyway the break is a short signal and the present attempt to retrace upward may be seen as healthy pr
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.65 USD
10.30 M USD
4.05 B USD
48.56 M
About Charles River Laboratories International, Inc.
Sector
CEO
James C. Foster
Website
Headquarters
Wilmington
Founded
1947
FIGI
BBG01S3LX741
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Related stocks
CRL: bullish megaphone patternA bullish trend is applicable above 206.00
Further bullish confirmation for a break above 216.00
The target price is set at 224.00.
The stop-loss price is set at 202.00.
An incomplete bullish megaphone pattern is busy developing.
Furthermore testing its 200-day simple moving average as well as its 2
Charles River Labs is Leaking and now Sinking. CRLWe are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statisti
CRL offering an early entry with a pocket pivot?* Exceptional earnings
* Very strong up trend
* High RS in the Healthcare industry
* Pocket pivot occurring on the right side of a rounded constructive basing pattern
Trade Idea:
* You can get in now as indicated
* Or if you're looking for a slight discount you can look for an entry near the $423.6
CRL Short PredictionA very short prediction for CRL.............................................................................................................................................................................................................................................................................
Charles River Laboratories Q2 Profit, Revenue RiseStock suggested by my dad as one to watch. Nice strong upward trend with financials also headed in the right way.
Might be a bit expensive at the moment looking at the RSI, so on the watch list waiting for a bit of a pullback prior to any entry decisions.
Worth a look.
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
CRL5145816
Charles River Laboratories International, Inc. 4.0% 15-MAR-2031Yield to maturity
5.95%
Maturity date
Mar 15, 2031
CRL5145814
Charles River Laboratories International, Inc. 3.75% 15-MAR-2029Yield to maturity
5.65%
Maturity date
Mar 15, 2029
CRL4900987
Charles River Laboratories International, Inc. 4.25% 01-MAY-2028Yield to maturity
5.46%
Maturity date
May 1, 2028
CRL4900988
Charles River Laboratories International, Inc. 4.25% 01-MAY-2028Yield to maturity
—
Maturity date
May 1, 2028
See all 0ADA bonds
Frequently Asked Questions
The current price of 0ADA is 166.80 USD — it hasn't changed in the past 24 hours. Watch CHARLES RIVER LABORATORIES COM STK USD0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange CHARLES RIVER LABORATORIES COM STK USD0.01 stocks are traded under the ticker 0ADA.
0ADA stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in CHARLES RIVER LABORATORIES COM STK USD0.01 price.
We've gathered analysts' opinions on CHARLES RIVER LABORATORIES COM STK USD0.01 future price: according to them, 0ADA price has a max estimate of 200.00 USD and a min estimate of 140.00 USD. Watch 0ADA chart and read a more detailed CHARLES RIVER LABORATORIES COM STK USD0.01 stock forecast: see what analysts think of CHARLES RIVER LABORATORIES COM STK USD0.01 and suggest that you do with its stocks.
0ADA reached its all-time high on Feb 27, 2025 with the price of 166.80 USD, and its all-time low was 166.80 USD and was reached on Feb 27, 2025. View more price dynamics on 0ADA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0ADA stock is 0.00% volatile and has beta coefficient of 0.43. Track CHARLES RIVER LABORATORIES COM STK USD0.01 stock price on the chart and check out the list of the most volatile stocks — is CHARLES RIVER LABORATORIES COM STK USD0.01 there?
Today CHARLES RIVER LABORATORIES COM STK USD0.01 has the market capitalization of 8.70 B, it has decreased by −1.69% over the last week.
Yes, you can track CHARLES RIVER LABORATORIES COM STK USD0.01 financials in yearly and quarterly reports right on TradingView.
CHARLES RIVER LABORATORIES COM STK USD0.01 is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
0ADA earnings for the last quarter are 2.34 USD per share, whereas the estimation was 2.08 USD resulting in a 12.73% surprise. The estimated earnings for the next quarter are 2.50 USD per share. See more details about CHARLES RIVER LABORATORIES COM STK USD0.01 earnings.
CHARLES RIVER LABORATORIES COM STK USD0.01 revenue for the last quarter amounts to 984.17 M USD, despite the estimated figure of 941.97 M USD. In the next quarter, revenue is expected to reach 985.23 M USD.
0ADA net income for the last quarter is 25.47 M USD, while the quarter before that showed −215.70 M USD of net income which accounts for 111.81% change. Track more CHARLES RIVER LABORATORIES COM STK USD0.01 financial stats to get the full picture.
No, 0ADA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 26, 2025, the company has 20.1 K employees. See our rating of the largest employees — is CHARLES RIVER LABORATORIES COM STK USD0.01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHARLES RIVER LABORATORIES COM STK USD0.01 EBITDA is 911.64 M USD, and current EBITDA margin is 22.93%. See more stats in CHARLES RIVER LABORATORIES COM STK USD0.01 financial statements.
Like other stocks, 0ADA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHARLES RIVER LABORATORIES COM STK USD0.01 stock right from TradingView charts — choose your broker and connect to your account.